On September 11, 2020 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta will be presenting at multiple virtual investor events in September 2020 (Press release, Kineta, SEP 11, 2020, View Source;utm_medium=rss&utm_campaign=kineta-presents-at-sept-2020-investor-conferences [SID1234565018]). Shawn Iadonato, Kineta Chief Executive Officer and Craig Philips, President, will present an overview of the company with a focus on its novel VISTA immuno-oncology program at the following events:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Opal Direct Investment Forum 2020
September 10, 2020 at 10:10-10:30AM Pacific Time
H.C. Wainwright 22nd Annual Global Investment Conference
September 15, 2020 at 6:30-6:50AM Pacific time
OTC Markets Group Life Sciences Investor Forum
September 17, 2020 at 1:00-1:30 Pacific time
FORCE Wealth Virtual Investor Conference
September 30, 2020 at 10:00-11:00AM Pacific Time